Octave Bioscience Funding & Investors
Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.
octavebio.comTotal Amount Raised: $91,000,072
Octave Bioscience Funding Rounds
Grant
$10,000,000
Grant Investors
Michael J. Fox FoundationSeries B
$32,500,070
Series B Investors
NovartisHikma VenturesBlue Venture FundDeerfield ManagementMerckIntermountain HealthcareSection 32Northpond VenturesEcho Health VenturesCasdin CapitalSeries B
$32,000,000
Series B Investors
Deerfield ManagementSection 32Northpond VenturesCasdin CapitalEcho Health VenturesSeries A
$14,000,000
Series A Investors
Blue Venture FundSection 32Echo Health VenturesSeed
$2,500,000
Funding info provided by Diffbot.